Titre:
  • Proliferation and estrogen signaling can distinguish patients at risk for early versus late relapse among estrogen receptor positive breast cancers.
Auteur:Bianchini, Giampaolo; Pusztai, Lajos; Karn, Thomas; Iwamoto, Takayuki; Rody, Achim; Kelly, Catherine M; Müller, Volkmar; Schmidt, Marcus; Qi, Yuan; Holtrich, Uwe; Becker, Sven; Santarpia, Libero; Fasolo, Angelica; Del Conte, Gianluca; Zambetti, Milvia; Sotiriou, Christos; Haibe-Kains, Benjamin; Symmans, W Fraser; Gianni, Luca
Informations sur la publication:Breast cancer research, 15, 5, page (R86)
Statut de publication:Publié, 2013-09
Sujet CREF:Cancérologie
Médecine pathologie humaine
Sciences bio-médicales et agricoles
MeSH keywords:Adult
Aged
Antineoplastic Agents, Hormonal -- therapeutic use
Breast Neoplasms -- drug therapy -- genetics -- metabolism -- mortality -- pathology
Cell Proliferation
Chemoradiotherapy, Adjuvant
Estrogens -- genetics -- metabolism
Female
Follow-Up Studies
Gene Expression Profiling
Gene Expression Regulation, Neoplastic
Humans
Middle Aged
Mitosis
Neoplasm Grading
Neoplasm Metastasis
Neoplasm Recurrence, Local
Neoplasm Staging
Prognosis
Receptors, Estrogen -- genetics -- metabolism
Risk
Signal Transduction
Tamoxifen -- therapeutic use
Tumor Markers, Biological -- genetics -- metabolism
Note générale:JOURNAL ARTICLE
SCOPUS: ar.j
Langue:Autre
Identificateurs:urn:issn:1465-5411
info:doi/10.1186/bcr3481
info:pii/bcr3481
info:scp/84884364251
info:pmid/24060333